Navigation Links
AlphaBio Centrix, LLC Announces a New Discovery for Programming Energetic Patches
Date:3/30/2012

LAS VEGAS, March 30, 2012 /PRNewswire/ -- AlphaBio Centrix, a Nevada-based biotech corporation, announced this week its development of a new bio-programming process – Infusion Technology. This is a term used in programming wearable TheraEX(TM) skin patches that can influence the human auric field, the energy field that surrounds all life forms.

When fully functional, this energy field is far reaching. In fact, in its basic form, it embodies seven major layers powered through seven major energy centers called Chakras.

"We are excited to share that we have discovered a way to use this auric field to influence specific bio-triggers which vibrate at a designated combination of frequencies," explains Richard Eaton, president, AlphaBio Centrix.

These frequencies communicate with, and enhance the body's natural energetic system. By wearing the TheraEX "Bio App" 24 hours a day for the duration of the protocol, the body is immersed in a corrective, informational and energetic exchange that promotes the balance of weak, disturbed and overactive energy.

AlphaBio Centrix uses a special substrate material for TheraEX ("Therapeutic Experience") that is sensitive to radio frequencies and is bonded to a non-latex woven medical pad manufactured by 3M Company. It's been formulated with an adhesive made for different types of skin conditions. This substrate material is then transformed by Infusion Technology, adding digital information onto the material.

These Bio Apps are an ideal alternative health care solution, and according to its recent research studies, mounting stress problems are causing an overwhelming effect on people's health and emotional problems. Stress factors include: today's uncertain work environment; and increasing workloads which may result in work-related injuries and health problems.

For more information on TheraEX(TM) visit: http://alphabiocentrix.com/products/thera-ex-apps-for-healing-and-frequency-medicine/ .

AlphaBio Centrix is also developing other products that are uniquely positioned to sell to homeopathic doctors and other health care professionals.

For more information on the company, visit: www.alphabiocentrix.com .

- Image 72dpi: Send2Press.com/mediaboom/12-0402-theraex_72dpi.jpg

This release was issued on behalf of the above organization by Send2Press(R), a unit of Neotrope(R). http://www.Send2Press.com


'/>"/>
SOURCE AlphaBio Centrix, LLC
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. China-Biotics, Inc. Announces Conference Call to Discuss First Quarter 2009 Financial Results
2. Odyssey Thera Announces Milestone Achievement in Pfizer Alliance
3. InNexus Biotechnology Announces Launch of Large Scale Primate Study of DXL625
4. Anesiva Announces Second Quarter 2008 Financial Results and Update
5. SGX Pharmaceuticals Announces Financial Results for the Three and Six Months Ended June 30, 2008
6. Insmed Announces Financial Results for Second Quarter and Six-Months Ended June 30, 2008
7. China Sky One Medical, Inc. Announces Conference Call to Discuss Second Quarter 2008 Results
8. China Yingxia International, Inc. Announces Conference Call to Discuss Second Quarter 2008 Results
9. ThirdBiotech Announces Kemeta as Newest Sponsor
10. Signalife Announces Intent to Withdraw From AMEX and Trade on the OTCBB
11. Chromos obtains interim order in connection with arrangement, announces annual and special meeting of shareholders and confirms mailing of information circular
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/6/2016)... (PRWEB) , ... December 06, 2016 , ... ... on December 1, 2016 asking the Federal Drug Administration (FDA) to consider OA ... of OA, OARSI is concerned about the growing population of OA patients, many ...
(Date:12/6/2016)... ... December 06, 2016 , ... ... announced today that the company has engaged in a collaborative research partnership with ... with the CSU Office of the Vice President for Research. This agreement is ...
(Date:12/6/2016)... SAN DIEGO , Dec. 6, 2016 /PRNewswire/ ... Santosh Kesari , MD, PhD, FANA, FAAN to ... experience in neurology and clinical trials to assist the ... treatment of stroke. The AmnioStem product is a universal donor ... shown therapeutic activity in animal models of stroke 1 ...
(Date:12/6/2016)... Dec. 6, 2016  The Texas Medical Center ... Australia (HISA) today announced the establishment of a ... between Australia and the Texas ... HISA and the Texas Medical Center, ... to create a global health innovation ecosystem where emerging ...
Breaking Biology Technology:
(Date:11/28/2016)... "The biometric system market projected to ... system market is in the growth stage and is ... biometric system market is expected to be valued at ... 16.79% between 2016 and 2022. Government initiative in adoption ... rising use of biometric technology in financial institutes and ...
(Date:11/22/2016)... MINNETONKA, Minn. , Nov. 22, 2016   ... that supports the entire spectrum of clinical research, is ... by Medical LiveWire Healthcare and Life Sciences Awards ... This award caps off an unprecedented year of recognition ... clinical trials for over 15 years. iMedNet ...
(Date:11/17/2016)... , Nov. 17, 2016 Global Market Watch: ... Biobanks (Disease-Based Banks, Population-Based Banks and Academics) market is to ... for Private Biobanks shows the highest Compounded Annual Growth Rate ... region during the analysis period 2014-2020. North ... of 9.95% followed by Europe at ...
Breaking Biology News(10 mins):